Congenital Heart Disease in Children
43
11
13
19
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.7%
2 terminated out of 43 trials
90.5%
+4.0% vs benchmark
7%
3 trials in Phase 3/4
5%
1 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (43)
Remote Cardiac Rehab for Adolescents With Congenital Heart Disease
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
Evaluation of Preoperative Preparation in Children Undergoing Cardiac Surgery or Catheterization
Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)
STeroids to REduce Systemic Inflammation After Infant Heart Surgery
Blood Based Assessment of sST2, Taken During and After Surgery, for Pediatric Patients With Heart Defects to Predict Heart Failure.
Feasibility and Efficiency of Screening for Neurodevelopmental Disorders by an Advanced Practice Nurse in Children With Congenital Heart Disease
Evaluation of an Investigational Wearable Vital Signs Monitoring Device in Healthy Infants
Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior
Erector Spinae Plane Block in Congenital Heart Disease Patients
Community-Based Remote Cardiac Rehabilitation Program for Pediatric Patients With Complex Congenital Heart Disease
Personalized Mobile App for Parents of Infants With Cardiac Disease
Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac Procedures
The Effect of DNS Therapy on Asymmetry in Children After Surgery of Congenital Heart Disease
WIReD: Wireless Interstage Remote Device Study
Non-invasive Monitoring of Cerebral Autoregulation in Perioperative Neonatal Cardiac Surgery
BAX602 in Preventing the Adhesion Around Great Cardiac Vessels in Pediatric Patients With Congenital Heart Disease Undergoing Re-do Open Heart Surgery (Japan Trial)
Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass
Artificial Intelligence-enabled ECG Detection of Congenital Heart Disease in Children: a Novel Diagnostic Tool
Cardiac Simulator for Surgical Planning